Description
CJC-1295 No DAC + Ipamorelin UK 10mg Research Peptide Blend
CJC-1295 No DAC + Ipamorelin UK 10mg is supplied by SPX Labs as a research peptide blend containing a nominal 5mg of CJC-1295 No DAC and 5mg of Ipamorelin. It is supplied exclusively for legitimate laboratory research, analytical testing and scientific evaluation.
Each product carries an identifiable batch reference designed to support traceability between the supplied research material and any analytical documentation associated with that specific batch.
CJC-1295 No DAC + Ipamorelin UK Research Material
This research material combines two synthetic peptides within a single nominal 10mg presentation: CJC-1295 No DAC 5mg and Ipamorelin 5mg.
CJC-1295 No DAC is associated with research into synthetic growth hormone-releasing hormone (GHRH) analogues, while Ipamorelin is a synthetic pentapeptide investigated within growth hormone secretagogue receptor research.
The CJC-1295 component of this product is specifically identified as No DAC. It should not be treated as interchangeable with CJC-1295 materials incorporating a Drug Affinity Complex (DAC).
SPX Labs supplies this blend in lyophilised form exclusively as a laboratory research material. It is not supplied as a medicine, supplement or therapeutic product, and SPX Labs does not provide instructions for human or veterinary administration.
Product Profile & Specifications
Product: CJC-1295 No DAC + Ipamorelin
Nominal total quantity: 10mg
CJC-1295 No DAC: 5mg nominal presentation
Ipamorelin: 5mg nominal presentation
Format: Lyophilised (freeze-dried) research material
Supplier: SPX Labs
Intended use: Laboratory research, analytical testing and scientific evaluation only
Batch identification: Provided on supplied material
Documentation: Batch-specific information available where applicable
The stated quantities describe the nominal SPX Labs product presentation. Where analytical testing has been performed on a particular batch, experimentally reported component content and other analytical results should be considered separately from the nominal presentation.
Analytical Testing & Batch Documentation
SPX Labs prioritises batch traceability and analytical transparency. Analytical information is associated with an identifiable product batch wherever applicable rather than being presented as a universal specification covering every CJC-1295 No DAC + Ipamorelin blend supplied.
For a multi-component research material, analytical documentation must also be interpreted according to the individual analytes actually reported by the laboratory. Testing of one component alone should not automatically be interpreted as analytical confirmation of the complete blend.
Batch-specific analytical results are therefore presented only where supporting documentation can be appropriately associated with the corresponding blend and batch.
SPX Labs does not represent analytical results from standalone Ipamorelin, standalone CJC-1295, CJC-1295 with DAC or an unrelated batch as analytical results for this blended research material.
Researchers can review available batch information through the SPX Labs COA Library and use the SPX batch-verification system to locate documentation associated with identifiable SPX batch references where available.
Understanding Blend Analytical Information
Analytical assessment of a peptide blend differs from simply applying an analytical result from one standalone component to the complete material. Where component-specific analytical information is reported, researchers should identify which analyte was measured, the corresponding result and the batch to which that result relates.
High-performance liquid chromatography (HPLC) is commonly used within peptide analysis to separate components within a sample and assess chromatographic characteristics. Mass spectrometry and other analytical techniques may also be used where appropriate to investigate peptide identity and composition.
A reported purity percentage should always be interpreted specifically in relation to the analytical method, analyte, tested sample and corresponding batch.
Importantly, a chromatographic purity result does not, by itself, establish sterility, endotoxin status, pharmaceutical approval, clinical efficacy or suitability for human or veterinary use.
SPX Labs therefore presents available analytical information as research-material documentation rather than as evidence of pharmaceutical or therapeutic suitability.
CJC-1295 No DAC + Ipamorelin Batch Traceability
Each CJC-1295 No DAC + Ipamorelin research material supplied by SPX Labs carries an identifiable SPX batch reference. This reference is designed to connect the supplied material with relevant product information and applicable supporting documentation.
Researchers should retain this reference when reviewing documentation, using the SPX batch-verification system or contacting SPX Labs regarding a particular product.
The SPX Labs Quality & Testing section provides further information about batch identification, analytical documentation and the internal research-material release approach used by SPX Labs.
This batch-focused approach helps prevent analytical results relating to a different peptide, formulation or batch from being incorrectly attributed to this research material.
Scientific Research Context
The two components of this blend originate from different areas of peptide research. CJC-related peptides have been investigated as synthetic analogues of growth hormone-releasing hormone, while Ipamorelin has been characterised within growth hormone secretagogue receptor research.
Researchers should evaluate the two components independently when reviewing scientific literature and should pay particular attention to the precise identity of the CJC peptide described in individual publications.
Peer-reviewed experimental characterisation of Ipamorelin is available through the Ipamorelin research indexed by PubMed.
For general scientific background concerning growth hormone-releasing hormone, researchers can consult the NCBI Bookshelf reference covering growth hormone physiology and GHRH.
These references provide scientific background concerning the individual research areas. They should not be interpreted as analytical documentation for the SPX Labs blend or as evidence that findings concerning one component necessarily apply to the combined material.
SPX Labs supplies this product solely as a research material and does not present findings from experimental or clinical literature as claims concerning the intended use of the product.
Storage & Laboratory Handling
Store the research material in accordance with the storage and handling information supplied with the applicable batch.
Appropriate laboratory procedures should be followed when handling research materials, and unnecessary exposure to adverse environmental conditions should be avoided.
Researchers and laboratories remain responsible for determining appropriate handling, storage and experimental procedures for their particular research environment and intended analytical application.
Frequently Asked Questions
What does the 10mg presentation contain?
The nominal product presentation consists of 5mg CJC-1295 No DAC and 5mg Ipamorelin, providing a nominal combined quantity of 10mg.
Is the CJC-1295 component the DAC variant?
No. This product is identified as containing CJC-1295 No DAC. SPX Labs treats CJC-1295 No DAC and DAC-containing CJC-1295 materials as distinct research materials.
Is batch documentation available for this blend?
SPX Labs provides batch-specific analytical information where applicable documentation can be appropriately associated with the corresponding blend and batch. Researchers should use the batch reference printed on the supplied material when checking available documentation.
Can a standalone peptide report be used as the COA for this blend?
No. Analytical results relate to the material, analyte, sample and batch identified in the supporting documentation. A report for a standalone component should not be represented as analytical documentation for the complete blend.
Does a purity result demonstrate that the material is suitable for human use?
No. Chromatographic purity does not by itself establish sterility, endotoxin status, pharmaceutical approval or suitability for human or veterinary use.
Is this research blend supplied for human use?
No. SPX Labs supplies this material exclusively for legitimate laboratory research, analytical testing and scientific evaluation. It is not supplied for human or veterinary consumption or administration.
Laboratory Research Notice
CJC-1295 No DAC + Ipamorelin supplied by SPX Labs is intended strictly for legitimate in-vitro laboratory research, analytical testing and scientific evaluation.
It is not supplied for human or veterinary consumption or administration and is not intended to diagnose, treat, cure or prevent disease.
SPX Labs — Precision Research. Verified Quality.
spxlabs.co.uk | info@SPXLabs.co.uk
